- Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.
- At that point, the molecule changes in legal status under the Federal Food, Drug, and Cosmetic Act and becomes a new drug subject to specific requirements of the drug regulatory system.
Marijuana
Nintedanib is an orally available tyrosine kinase receptor antagonist that inhibits collagen formation and is used to treat idiopathic pulmonary fibrosis. Elevations in serum enzyme levels during nintedanib therapy are not uncommon, but it has yet to be implicated in cases of clinically apparent liver injury with jaundice.
List of Controlled Substances
Lists of Scheduling Actions, Controlled Substances, Regulated Chemicals (PDF) (December 2020)
This document is a general reference and not a comprehensive list. This list describes the basic or parent chemical and does not describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be controlled substances.
| Scheduling Actions | Controlled Substances | List I and II Regulated Chemicals |
|---|---|---|
| Alphabetical Order | Alphabetical Order | Alphabetical Order |
| Chronological Order | DEA Drug Code Number | DEA Number |
| CSA Schedule | List Number | |
| Illicit Uses and Threshold Quantities |
Exempted Lists
Exempt Anabolic Steroid Products
Exempt Anabolic Steroid Products Procedures
Exempt Anabolic Steroid Products List (PDF) (November 5, 2020)
Exempt Chemical Preparations
Exempt Chemical Preparations List (PDF) (November 7, 2017) For Application Dates Through December 31, 2016
Exempted Prescription Products
Exempted Prescription Products Application
Exempted Prescription Products List (PDF) (January 11, 2021)
Lists of Controlled Substances Disclaimer
Section 812 of the Controlled Substances Act (21 U.S.C. §801 et seq.) (CSA) lists substances which were controlled in 1970 when the CSA was enacted. Since then many substances have been added, removed, or transferred from one schedule to another. The current list of controlled substances can be found in section 1308 of the most recent issue of Title 21 Code of Federal Regulations (CFR) Part 1300 to end (21 CFR §1308) and the final rules which were published in the Federal Register subsequent to the issuance of the CFR.
These lists describe the basic or parent chemical and do not describe the salts, isomers, salts of isomers, esters, ethers, and derivatives which may be controlled substances. These are not comprehensive lists so please note that a substance need not be listed as a controlled substance to be treated as a scheduled substance for criminal prosecution. The 'Other Names' column, provides some examples of alternate names for certain compounds, and in some instances provides examples of 'positional isomers'. If outside parties want to ensure that a compound is not considered a scheduled substance or listed chemical, they should write the DEA, Drug and Chemical Evaluation Section (DRE), Diversion Control Division, 8701 Morrissette Drive, Springfield, Virginia 22152, for an official determination.
A substance (not included on these lists) may also be regulated as a controlled substance analogue. A controlled substance analogue is a substance which is intended for human consumption, is structurally substantially similar to a schedule I or schedule II substance, is pharmacologically substantially similar to a schedule I or schedule II substance, or is represented as being similar to a schedule I or schedule II substance and is not an approved medication in the United States. See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.
Defined Abbreviations
| Defined Abbreviation | Controlled Substance Analogue |
|---|---|
| 2C-B | 4-Bromo-2,5-dimethoxyphenethylamine |
| 2C-T-7 | 2,5-Dimethoxy-4(n)-propylthiophenethylamine |
| BZP | N-Benzylpiperazine |
| DMT | Dimethyltryptamine |
| DOM | 4-Methyl-2,5-dimethoxyamphetamine |
| GBL | Gamma butyrolactone |
| GHB | Gamma hydroxybutyric acid, gamma hydroxybutyrate, 4-hydroxybutanoic acid, sodium oxybate |
| LAAM | Levo-alphacetylmethadol |
| LSD | Lysergic acid diethylamide, lysergide |
| MDA | 3,4-Methylenedioxyamphetamine |
| MDE | 3,4-Methylenedioxy-N-ethylamphetamine |
| MDMA | 3,4-Methylenedioxymethamphetamine |
| MPPP | 1-Methyl-4-phenyl-4-propionoxypiperidine |
| P2P | Phenyl-2-propanone, phenylacetone |
| PCC | 1-Piperidinocyclohexanecarbonitrile |
| PCE | N-Ethyl-1-phenylcyclohexylamine |
| PCH | 1-Phenylcyclohexylamine |
| PCP | 1-(1-Phenylcyclohexyl)piperidine, phencyclidine |
| PEPAP | 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine |
| PHP | 1-(1-Phenylcyclohexyl)pyrrolidine |
| SPA | (-)-1-Dimethylamino-1,2-diphenylethane |
| TCP | 1-[1-(2-Thienyl)cyclohexyl]piperidine |
| TCPy | 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine |
| THC | Tetrahydrocannabinols |
| THG | Tetrahydrogestrinone |
Definition of Controlled Substance Schedules
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are divided into five schedules. An updated and complete list of the schedules is published annually in Title 21 Code of Federal Regulations (C.F.R.) §§1308.11 through 1308.15. Substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused. Some examples of the drugs in each schedule are listed below.
Schedule I Controlled Substances
Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.
Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ('Ecstasy').
Schedule II/IIN Controlled Substances (2/2N)
Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence.
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone.
Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).
Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.
Schedule III/IIIN Controlled Substances (3/3N)
Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.
Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®).
Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone.
Schedule IV Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances in Schedule III.
Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®).
Schedule V Controlled Substances
Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics.
Subject: New Drug Names Name
Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.